Ignite Creation Date:
2024-05-05 @ 11:56 AM
Last Modification Date:
2024-10-26 @ 9:17 AM
Study NCT ID:
NCT00185068
Status:
COMPLETED
Last Update Posted:
2005-09-16
First Post:
2005-09-09
Brief Title:
An Examination of the Safety and Blood Pressure Lowering Effect of Increasing Doses of Benicar and Benicar HCT in Patients With Hypertension
Sponsor:
Daiichi Sankyo
Organization:
Daiichi Sankyo
Study Overview
Official Title:
A Prospective Open Label Titration Study to Assess the Efficacy and Safety of Benicar and Benicar HCT in Patients With Stage II Systolic Hypertension
Status:
COMPLETED
Status Verified Date:
2005-09
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
No
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
Effect of increasing doses of olmesartan medoxomil and olmesartan medoxomilhydrochlorothiazide on blood pressure in patients with hypertension
Detailed Description:
None
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
None
Is a FDA Regulated Device?:
None
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None